Atlas Trials

Oral Rigosertib for Squamous Cell Carcinoma

Clinical trial NCT01807546 · COMPLETED

Trial details

NCT number
NCT01807546
Sponsor
Traws Pharma, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Squamous Cell CarcinomaAnal Squamous Cell CarcinomaLung Squamous Cell CarcinomaCervical Squamous Cell CarcinomaEsophageal Squamous Cell CarcinomaSkin Squamous Cell CarcinomaPenile Squamous Cell Carcinoma
Start date
2013-03-01
Primary completion
2015-03-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.